Klassen Preston Insider Trades

Insider Trading History

Track insider trading activity for Klassen Preston. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.5M 1,898,000 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $392k 48,055 shares
Last Trade
Jun 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$95.9k 12,000 shares
$7.99
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $5.51M 675,000 shares
Last Trade
Jan 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$675k 675,000 shares
$1.00
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $294k 36,055 shares
Last Trade
Jan 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.6k 31,445 shares
$1.26
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $551k 67,500 shares
Last Trade
Jan 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$101k 67,500 shares
$1.49
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $4.31M 528,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 528,000 shares
$2.01
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $979k 120,000 shares
Last Trade
Jan 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 120,000 shares
$1.30
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $1.84M 225,000 shares
Last Trade
Aug 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$306k 225,000 shares
$1.36
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
President & Head Of R & D
Holding Value $2.86M 350,000 shares
Last Trade
Jun 12, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$511k 350,000 shares
$1.46
$8.16
Metacrine
Metacrine MTCR
Director
Holding Value $805k 1,384,116 shares
Last Trade
Mar 23, 2023 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$480k 842,211 shares
$0.57
$0.58
Metacrine
Metacrine MTCR
Director
Holding Value $0 0 shares
Last Trade
Mar 23, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$480k 842,211 shares
$0.57
$0.58
JATT Acquisition
JATT Acquisition JATT
President And COO
Holding Value $0 0 shares
Last Trade
Mar 20, 2023 Sale
$3.89M 476,756 shares
$8.16
$8.16
Metacrine
Metacrine MTCR
President & CEO
Holding Value $315k 541,905 shares
Last Trade
Jan 26, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$184k 380,605 shares
$0.48
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $536k 922,510 shares
Last Trade
Apr 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$598 1,173 shares
$0.51
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $562k 967,258 shares
Last Trade
Apr 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61.1k 104,500 shares
$0.58
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $502k 862,758 shares
Last Trade
Feb 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396k 842,211 shares
$0.47
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $11.9k 20,547 shares
Last Trade
May 20, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$74.8k 20,547 shares
$3.64
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $144k 247,500 shares
Last Trade
Feb 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.5M 247,500 shares
$10.09
$0.58
Metacrine
Metacrine MTCR
President & CEO
Holding Value $0 0 shares
Last Trade
Sep 15, 2020 Sale
No data
No data
$0.58
Arena Pharmaceuticals
Arena Pharmaceuticals ARNA
EVP And CMO
Holding Value $7M 70,000 shares
Last Trade
Mar 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.12M 70,000 shares
$44.60
$99.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up